» Authors » Ahmed A K Hasan

Ahmed A K Hasan

Explore the profile of Ahmed A K Hasan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 243
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Musunuru K, Bernstein D, Cole F, Khokha M, Lee F, Lin S, et al.
Circ Genom Precis Med . 2018 Apr; 11(4):e002178. PMID: 29654098
The National Institutes of Health have made substantial investments in genomic studies and technologies to identify DNA sequence variants associated with human disease phenotypes. The National Heart, Lung, and Blood...
2.
Everett B, Pradhan A, Solomon D, Paynter N, MacFadyen J, Zaharris E, et al.
Am Heart J . 2013 Jul; 166(2):199-207.e15. PMID: 23895801
Background: Inflammation plays a fundamental role in atherothrombosis. Yet, whether direct inhibition of inflammation will reduce the occurrence of adverse cardiovascular outcomes is not known. Design: The Cardiovascular Inflammation Reduction...
3.
Musunuru K, Roden D, Boineau R, Bristow M, McCaffrey T, Newton-Cheh C, et al.
J Am Heart Assoc . 2012 Nov; 1(2):e000554. PMID: 23130127
No abstract available.
4.
Fuster V, Bhatt D, Califf R, Michelson A, Sabatine M, Angiolillo D, et al.
Circulation . 2012 Sep; 126(13):1645-62. PMID: 23008471
No abstract available.
5.
Akesson P, Herwald H, Rasmussen M, Hakansson K, Abrahamson M, Hasan A, et al.
Microbiology (Reading) . 2010 Aug; 156(Pt 12):3660-3668. PMID: 20705662
Since the late 1980s, a worldwide increase of severe Streptococcus pyogenes infections has been associated with strains of the M1 serotype, strains which all secrete the streptococcal inhibitor of complement-mediated...
6.
Hasan A, Marder V
Thromb Res . 2005 Oct; 117(1-2):229-30. PMID: 16225912
No abstract available.
7.
Nieman M, Pagan-Ramos E, Warnock M, Krijanovski Y, Hasan A, Schmaier A
FEBS Lett . 2004 Dec; 579(1):25-9. PMID: 15620686
The angiotensin converting enzyme breakdown product of bradykinin, bradykinin 1-5 (RPPGF), inhibits thrombin-induced human or mouse platelet aggregation. RPPGF binds to the exodomain of human protease-activated receptor 1 (PAR1). Studies...
8.
Nieman M, Warnock M, Hasan A, Mahdi F, Lucchesi B, Brown N, et al.
J Pharmacol Exp Ther . 2004 Jun; 311(2):492-501. PMID: 15210836
Thrombin and protease-activated receptor 1 (PAR1) activation antagonists were prepared based upon the peptide RPPGF, the angiotensin-converting enzyme breakdown product of bradykinin. A library of 72 peptides consisting of d...
9.
Hasan A, Warnock M, Nieman M, Srikanth S, Mahdi F, Krishnan R, et al.
Am J Physiol Heart Circ Physiol . 2003 Feb; 285(1):H183-93. PMID: 12598231
Investigations determined the mechanism(s) by which Arg-Pro-Pro-Gly-Phe (RPPGF) inhibits thrombin-induced platelet activation. High concentrations of RPPGF inhibit thrombin-induced coagulant activity. RPPGF binds to the active site of thrombin by forming...
10.
Prieto A, Ma H, Huang R, Khan G, Schwartz K, Schmaier A, et al.
Cardiovasc Res . 2002 Mar; 53(4):984-92. PMID: 11922908
Objective: Thrombin activates platelets and contributes to the occlusion of arteries following thrombolytic therapy or angioplasty. Thrombostatin (RPPGF), the angiotensin converting enzyme degradation product of bradykinin, inhibits alpha-thrombin induced platelet...